secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2024-05-09T23:59:59+00:00
Accession:  0000950170-24-056089
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance Q1 revenue +19% to $300.4M; raises FY2024 EBITDA guidance; COO to depart June 30
--------------------------------------------------------------------------------

- Q1 revenue $300.4M (+19% YoY); net loss narrowed to $21.1M from $34.2M.
- Adjusted EBITDA $27.7M (9.2% of revenue), up from $10.1M; FY2024 Adjusted EBITDA guidance raised to $88–$98M.
- Clinician base grew 15% to 6,866; visit volumes up 15% to 1.9M; Center Margin $94.7M (31.5% of revenue).
- President & COO Danish Qureshi notified departure effective June 30, 2024.
- Q2 2024 guidance: revenue $297–$315M, Adjusted EBITDA $20–$26M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000095017024056089/0000950170-24-056089-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000095017024056089/lfst-20240506.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-056089

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer